Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

18 trials with published results (6%)

Research Maturity

127 completed trials (46% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.0%

14 terminated out of 278 trials

Success Rate

90.1%

+3.6% vs benchmark

Late-Stage Pipeline

5%

14 trials in Phase 3/4

Results Transparency

14%

18 of 127 completed with results

Key Signals

18 with results90% success14 terminated

Data Visualizations

Phase Distribution

160Total
Not Applicable (96)
Early P 1 (2)
P 1 (17)
P 2 (31)
P 3 (9)
P 4 (5)

Trial Status

Completed127
Unknown75
Recruiting32
Terminated14
Not Yet Recruiting13
Withdrawn9

Trial Success Rate

90.1%

Benchmark: 86.5%

Based on 127 completed trials

Clinical Trials (278)

Showing 20 of 20 trials
NCT06511622CompletedPrimary

Impact of Immune Status on Secondary Infections in Patients With Acute Respiratory Failure

NCT07634419Not ApplicableNot Yet Recruiting

Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT

NCT04365101Phase 1Terminated

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

NCT04401111Active Not Recruiting

One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

NCT04371029Not ApplicableCompletedPrimary

Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS

NCT05137795Phase 3Withdrawn

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

NCT06701682Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

NCT06701669Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

NCT06703073Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

NCT06701656Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

NCT04402879Not ApplicableCompleted

CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals

NCT05219643Not ApplicableCompletedPrimary

Effect of Nava on Weaning Outcome in Patients With Mechanical Ventilation

NCT06823804CompletedPrimary

Electrical Impedance Tomography-Derived Dorsal Recruitment-to-Inflation Ratio Identifies PEEP Responsiveness and Risk Phenotypes in ARDS

NCT02149589Not ApplicableCompletedPrimary

Lung Imaging for Ventilatory Setting in ARDS

NCT04068012Not ApplicableRecruiting

Clinical Decision Support Tool in PARDS Pilot Study

NCT07370610Active Not RecruitingPrimary

Electrical Impedance Tomography-Based Dynamic Ventilation-Perfusion Functional Phenotype Trajectory in Acute Respiratory Distress Syndrome

NCT07193719Phase 1Recruiting

Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children

NCT06737432Not ApplicableActive Not Recruiting

Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

NCT07445061Not Yet Recruiting

Machine Learning Prediction of Mortality After Prone Positioning in ARDS

NCT06179771Not ApplicableRecruiting

Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.

Scroll to load more

Research Network

Activity Timeline